Correlation Between AN2 Therapeutics and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on AN2 Therapeutics and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Zentalis Pharmaceuticals.
Diversification Opportunities for AN2 Therapeutics and Zentalis Pharmaceuticals
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between AN2 and Zentalis is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Zentalis Pharmaceuticals
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 0.4 times more return on investment than Zentalis Pharmaceuticals. However, AN2 Therapeutics is 2.5 times less risky than Zentalis Pharmaceuticals. It trades about -0.22 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.31 per unit of risk. If you would invest 138.00 in AN2 Therapeutics on October 26, 2024 and sell it today you would lose (13.00) from holding AN2 Therapeutics or give up 9.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| AN2 Therapeutics |
| Zentalis Pharmaceuticals |
AN2 Therapeutics and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Zentalis Pharmaceuticals
The main advantage of trading using opposite AN2 Therapeutics and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| AN2 Therapeutics vs. Surrozen | AN2 Therapeutics vs. Armata Pharmaceuticals | AN2 Therapeutics vs. Pasithea Therapeutics Corp | AN2 Therapeutics vs. Aditxt Inc |
| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |